The link between the nose and lung, perennial rhinitis and asthma - Is it the same disease?

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 52, Issue SUPPL. 36, 1997, Pages 20-28

  Rowe Jones, J M ^a  

^a CHARING CROSS HOSPITAL   (United Kingdom)

Author keywords

Asthma; Eosinophilia; Lung; Nose; Pathology; Perennial rhinitis; Polyposis

Indexed keywords

CORTICOSTEROID; CYTOKINE; EOSINOPHIL CATIONIC PROTEIN; GLUCOCORTICOID; HISTAMINE; INTERLEUKIN 4; INTERLEUKIN 5; METHACHOLINE; VASCULAR CELL ADHESION MOLECULE 1;

ASTHMA; AUTONOMIC DYSFUNCTION; BRONCHUS HYPERREACTIVITY; CONFERENCE PAPER; EOSINOPHILIA; HUMAN; INTRANASAL DRUG ADMINISTRATION; PERENNIAL RHINITIS; PREVALENCE; PRIORITY JOURNAL; SINUSITIS; T LYMPHOCYTE ACTIVATION;

ASTHMA; AUTONOMIC NERVOUS SYSTEM; BRONCHI; BRONCHIAL HYPERREACTIVITY; EOSINOPHILS; GLUCOCORTICOIDS; HUMANS; INFLAMMATION; LUNG; NOSE; RHINITIS, ALLERGIC, PERENNIAL; SINUSITIS; TRACHEA;

EID: 0030754161     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/j.1398-9995.1997.tb04818.x     Document Type: Conference Paper

References (124)

1. Mygind N, Naclerio RM. Definition, classification, terminology. In: Mygind N, Naclerio RM, editors. Allergic and non-allergic rhinitis. Copenhagen: Munksgaard, 1993:11-4.
2. Van Cauwenberge PB, Ingels KJAO. Rhinitis: the spectrum of the disease. In: Busse WW, Holgate ST, editors. Asthma and rhinitis. 1st edition. Oxford: Blackwell Scientific Publications, 1995:6-11.
3. Moneret-Vautrin DA, Jankowski R, Béné MC et al. NARES: a model of inflammation caused by activated eosinophils? Rhinology 1992;30:161-8.
4. Gwaltney JM, Phillips CD, Miller RD, Riker DK. Computed tomographic study of the common cold. N Engl J Med 1994;330(1):25-30.
5. International Rhinitis Management Working Group. Definition and classification of rhinitis. Allergy 1994;49(Suppl. 19):5.
6. Mackay IS. Classification and differential diagnosis of rhinitis. Eur Respir Rev 1994;4(20):245-7.
7. American Thoracic Society. Standards for diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis 1987;136:228-30.
8. International Asthma Management Project. Definition, diagnosis and classification. Allergy 1992;47(Suppl. 13):1-5.
9. Reed CE. Introduction. In: Busse WW, Holgate ST, editors. Asthma and rhinitis Volume 1. Oxford: Blackwell Scientific Publications, 1995:XXI-V.
10. Uddman R, Sundler E Neuropeptides in the airway: a review. Am Rev Respir Dis 1987;136(6):S3-8.
11. Widdicombe JG. The physiology of the nose. Clin Chest Med 1986;7(2):159-70.
12. Stammberger H, Wolf G. Headaches and sinus disease: the endoscopic approach. Ann Otol Rhinol Laryngol 1988;97(5)(Suppl.):3-23.
13. Mygind N, Dahl R. Challenge tests in nose and bronchi: pharmacological modulation of rhinitis and asthma. Clin Exp Allergy 1996;26(Suppl. 3):39-43.
14. Picado C. Response of nose and bronchi to exercise in asthma and rhinitis: similarities and differences. Clin Exp Allergy 1996;26(Suppl. 3):36-8.
15. Dahl R. Rhinitis and asthma. In: Mygind N, Naclerio R, editors. Allergic and non-allergic rhinitis. Copenhagen: Munksgaard, 1993:184-8.
16. Smith JM. Epidemiology. In: Mygind N, Naclerio RM, editors. Allergic and non-allergic rhinitis. Copenhagen: Munksgaard, 1993:15-22.
17. van der Baan S. The case for intranasal corticosteroids. Nasal Inflam Today 1996;3(1):4.
18. Sibbald B, Rink E. Epidemiology of seasonal and perennial rhinitis: clinical presentation and medical history. Thorax 1991;46:895-901.
19. Mygind N, Dirksen A, Johnsen NJ, Weeke B. Perennial rhinitis: analysis of skin testing, serum IgE, and blood and smear eosinophilia in 201 patients. Clin Otolaryngol 1978;3:189-96.
20. Settipane GA. Nasal manifestations of systemic disease. In: Settipane GA, editor. Rhinitis. Providence, RI: OceanSide Publications, Inc., 1991:197-207.
21. Drake-Lee AB, Lowe D, Swanston A, Grace A. Clinical profile and recurrence of nasal polyps. J Laryngol Otol 1984;98:783-93.
22. Hagy GW, Settipane GA. Risk factors for the development of asthma and allergic rhinitis: a 7 year follow-up of college students. J Allergy Clin Immunol 1976;58:330-6.
23. Azzawi M, Bradley B, Jeffery PK et al. Identification of activated T lymphocytes and eosinophils in bronchial biopsies in stable atopic asthma. Am Rev Respir Dis 1990;142:1407-13.
24. Varney VA, Jacobson MR, Sudderick RM et al. Immuno-m'stology of the nasal mucosa following allergen-induced rhinitis. Am Rev Respir Dis 1992;146:170-6.
25. Peroni DG, Feather IH, Wilson SJ, Holgate ST, Howarth PH. Comparative study of the T-lymphocyte subsets in the nasal mucosa of perennial and seasonal rhinitics [Abstract]. Eur Respir J 1994;7:240s.
26. Feather IH, Wilson SJ. Eosinophils in rhinitis. In: Busse WW, Holgate ST, editors. Asthma and rhinitis. 1st edition. Oxford: Blackwell Scientific Publications, 1995: 347-63.
27. Mygind N. Pathophysiology of allergic rhinitis. Eur Respir Rev 1994;4(20):248-51.
28. Andersson M, Greiff L, Svensson C, Wollmer P, Persson CGA. Allergic and nonallergic rhinitis. In: Busse WW, Holgate ST, editors. Asthma and rhinitis. 1st edition. Oxford: Blackwell Scientific Publications, 1995:145-53.
29. Simons FER. Antihistamines. In: Mygind N, Naclerio R, editors. Allergic and non-allergic rhinitis. Copenhagen: Munksgaard, 1993:123-36.
30. International Rhinitis Management Working Group. Treatment of allergic rhinitis. Allergy 1994;19(49):19-23.
31. Sears MR, Herbison GP, Holdaway MD, Hewitt CJ, Flannery EM, Silva PA. The relative risks of sensitivity to grass pollen, house dust mite and cat dander in the development of childhood asthma. Clin Exp Allergy 1989;19(4):419-24.
32. Bradding P, Feather IH, Howarth PH et al. Interleukin 4 is localised to and released by human mast cells. J Exp Med 1992;176:1381-6.
33. Djukanovic R, Wilson SJ, Howarth PH. Pathology of rhinitis and bronchial asthma. Clin Exp Allergy 1996; 26(Suppl. 3):44-51.
34. Howarth P. Cromoglycate. In: Mygind N, Naclerio RM, editors. Allergic and non-allergic rhinitis. Copenhagen: Munksgaard, 1993:101-4.
35. Bradding PH, Feather IH, Wilson S, Bardin P, Holgate ST, Howarth PH. Immunolocalisation of cytokines in the nasal mucosa of normal and perennial rhinitis subjects: the mast cell as a source of IL-4, IL-5 and IL-6 in human allergic inflammation. J Immunol 1993;151(7):3853-65.
36. Bradding P, Roberts JA, Britten KM et al. Interleukin-4, -5, -6, and tumor necrosis factor-alpha in normal and asthmatic airways: evidence for the human mast cell as a source of these cytokines. Am J Respir Cell Mol Biol 1994;10:471-80.
37. Yrng S, Durham SR, Jacobson MR et al. T lymphocytes and mast cells express messenger RNA for interleukin-4 in the nasal mucosa in allergen-induced rhinitis. Immunology 1994;82:200-6.
38. Iliopoulos I, Proud D, Togias AG et al. Immunopharmacology of nasal allergic reactions. In: Settipane GA, editor. Rhinitis. 2nd edition. Providence: OceanSide Publications, Inc., 1991:27-37.
39. Broide D, Paine MM, Firestein G. Eosinophils express interleukin-5 and granulocyte macrophage-colony stimulating factor mRNA at sites of allergic inflammation in asthmatics. J Clin Invest 1992;90:1414-24.
40. Sur S, Adolphson CR, Gleich GJ. Eosinophils. Biochemical and cellular aspects. In: Middleton E, Reed CE, Ellis EF, Adkinson NF, Yunginger JQ, Busse WW, editors. Allergy. Principles and practice. Volume 1. St. Louis: Mosby Year Book Inc., 1993:169-200.
41. Howarth P. The cellular basis for allergic rhinitis. Clin Exp Allergy 1995;50(Suppl. 23):6-10.
42. Jordana M, Dolovich J, Ohno I, Finotto S, Denburg J. Nasal polyposis: a model for chronic inflammation. In: Busse WW, Holgate ST, editor. Asthma and rhinitis. 1st edition. Oxford: Blackwell Scientific Publications, 1995:156-64.
43. Venge P, Carlson M. Eosinophil granule proteins in bronchial asthma. In: Kay AB, editor. Eosinophils, allergy and asthma. Oxford: Blackwell Scientific Publications, 1990: 96-105.
44. Ackerman V, Marini M, Vittori E, Bellini A, Vassali G, Mattoli S. Detection of cytokines and their cell sources in bronchial biopsy specimens from asthmatic patients: relationship to atopic status, symptoms and level of airway hyperresponsiveness. Chest 1994;105(3):687-96.
45. Linder A, Venge P, Deuschl H. Eosinophil cationic protein and myeloperoxidase in nasal secretion as markers of inflammation in allergic rhinitis. Allergy 1987;42:583-90.
46. Klementsson H, Svensson C, Andersson M, Venge P, Pipkorn U, Persson C. Eosinophils, secretory responsiveness and glucocorticoid-induced effects on the nasal mucosa during a weak pollen season. Clin Exp Allergy 1991;21:705-10.
47. Klementsson H, Andersson M. Eosinophil chemotactic activity of topical PAF on the human nasal mucosa. Eur J Clin Pharmacol 1992;42:295-9.
48. Andersson M, Andersson P, Venge P, Pipkorn U. Eosinophils and eosinophil cationic protein in nasal lavages in allergen-induced hyperresponsiveness: effects of topical glucocorticosteroid treatment. Allergy 1989;44:342-8.
49. Klementsson H, Andersson M, Pipkorn U. Allergen-induced increase in nonspecific nasal reactivity is blocked by antihistamines without a clear-cut relationship to eosinophil influx. J Allergy Clin Immunol 1990;86;466-72.
50. Durham SR, Ying S, Varney VA et al. Cytokine messenger RNA expression for IL-3, IL-4, IL-5, and granulocyte/ macrophage-colony-stimulating factor in the nasal mucosa after local allergen provocation: relationship to tissue eosinophilia. J Immunol 1992;148:2390-4.
51. Ying S, Durham SR, Barkans J et al. T cells are the principal source of interleukin-5 mRNA in allergen-induced rhinitis. Am J Respir Cell Mol Biol 1993;9:356-60.
52. Robinson D, Hamid Q, Yrng S et al. Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. N Engl J Med 1992;326:298-304.
53. Borum P. Nasal metacholine challenge: a test for the measurement of nasal reactivity. J Allergy Clin Immunol 1979;63(4):253-7.
54. Gerth van Wijk R, Dieges PH. Comparison of nasal responsiveness to histamine, metacholine and phento-lamine in allergic rhinitis patients and controls. Clin Allergy 1987;17(6):563-70.
55. McLean JA, Mathews KP, Solomon WR, Brayton PR, Ciarkowski AA. Effect of histamine and metacholine on nasal airway resistance in atopic and non-atopic subjects. Comparison with bronchial challenge and skin test responses. J Allergy Clin Immunol 1977;59(2):165-70.
56. Mullins RJ, Olson LG, Sutherland DC. Nasal histamine challenges in symptomatic allergic rhinitis. J Allergy Clin Immunol 1989;83:955-9.
57. van de Heyning PH, Haesendonck J, Creten W, de Saegher D, Claes J. Histamine nasal provocation test. An evaluation of active anterior rhinomanometry and of threshold criteria of provocative dose. Allergy 1989;44:482.
58. De Graaf T, Koenders S, Garrelds IM, Gerth van Wijk R. The relationships between nasal hyperreactivity, quality of life and nasal symptoms in perennial allergic rhinitis [Abstract]. Second symposium on experimental rhinology and immunology of the nose, 1996:42.
59. Townley RG. Allergic rhinitis and airway reactivity to mediators. In: Settipane GA, editor. Rhinitis. Providence, RI: OceanSide Publications, Inc., 1991:125-33.
60. Dahl R, Johansson SA. Importance of duration of treatment with inhaled budesonide on the immediate and late bronchial reaction. Eur J Respir Dis 1982;63(Suppl. 122): 167-75.
61. Masuyama K, Rak S, Jacobson MR, Lôwhagen O, Hamid Q, Durham SR. Rhinitis at the cellular level. Eur Respir Rev 1994;4(20):252-5.
62. Mygind N, Dahl R. The rationale for use of topical steroids in allergic rhinitis. Clin Exp Allergy 1996;26(Suppl. 3):2-10.
63. Garrelds IM, De Graaf-in't Veld T Nahori M, Vargaftig BB, Gerth van Wijk R, Zijlstra FJ. Effect of glucocorticoid treatment on interleukin-5 and eosinophilic cationic protein in nasal lavages of allergic rhinitis patients [Abstract]. Second symposium on experimental rhinology and immunology of the nose, 1996:41.
64. Holm AF, Godthelp T, Vroom TM, Rijntjes E, Fokkens WJ. Safety and efficacy of one-year treatment with fluticasone propionate on clinical signs and inflammatory cells in the nasal mucosa of allergic perennial rhinitis patients [Abstract]. Second symposium on experimental rhinology and immunology of the nose, 1996;43-4.
65. Robinson DS, Hamid Q, Ying S et al. Prednisolone treatment in asthma is associated with modulation of bronchoalveolar lavage cell interleukin-4, interleukin-5 and interferon-gamma cytokine gene expression. Am Rev Respir Dis 1993;148:401-6.
66. Konno A, Yamakoshi T, Terada N, Fujita Y. Mode of action of a topical steroid on immediate phase reaction after antigen challenge and nonspecific nasal hyperreactivity in nasal allergy. Int Arch Allergy Immunol 1994;103:79-87.
67. Carlson M, Håkansson L, Peterson C, Stålenheim G, Venge P. Secretion of granule proteins from eosinophils and neutrophils is increased in asthma. J Allergy Clin Immunol 1991; 87(1):27-33.
68. Jankowski R, Béné MC, Moneret-Vautrin AD et al. Immunohistological characteristics of nasal polyps. A comparison with healthy mucosa and chronic sinusitis. Rhinology 1989;Suppl. 8:51-8.
69. Hauser U, Rudack C, Wagenmann M, Bachert C. Cytokine levels in different kinds of nasal polyps [Abstract]. Second symposium on experimental rhinology and immunology of the nose, 1996:43.
70. Kanny G, Jankowski R, Béné MC et al. Clinical and immunohistological aspects of non-allergic rhinitis with eosinophilic syndrome (NARES) - follow-up of 50 patients [Abstract]. Second symposium on experimental rhinology and immunology of the nose, 1996:45.
71. Harlin SL, Ansel DG, Lane SR, Myers J, Kephart GM, Gleich GJ. A clinical and pathological study of chronic sinusitis: the role of the eosinophil. J Allergy Clin Immunol 1988;81:867-75.
72. Stoop AE, van der Heijden HAMD, Biewenga J, van der Baan S. Eosinophils in nasal polyps and nasal mucosa: an immunohistochemical study. J Allergy Clin Immunol 1993; 91:616-22.
73. Hamilos DL, Leung DY, Wood R et al. Chronic hyperplastic sinusitis: association of tissue eosinophilia with mRNA expression of granulocyte macrophage-colony stimulating factor and interleukin-3. J Allergy Clin Immunol 1993;92(1):39-48.
74. Numi A, Amitani R, Ikeda T, Kubo Y, Tanaka E, Kuze F. Inflammatory bronchial polyps associated with asthma: resolution with inhaled corticosteroid. Eur Respir J 1995; 8:1237-9.
75. Yamashita T, Tsuji H, Maeda N, Tomoda K, Kumazawa T. Etiology of nasal polyps associated with aspirin sensitive asthma. Rhinology 1989;Suppl. 8:15-24.
76. Nasser SM, Pfister R, Christie PE et al. Inflammatory cell populations in bronchial biopsies from aspirin-sensitive asthmatic subjects. Am J Respir Crit Care Med 1996; 153(1):90-6.
77. Samter M, Beers RF. Intolerance to aspirin: clinical studies and consideration of its pathogenesis. Ann Intern Med 1968;68:975.
78. Stammberger H. Functional endoscopic sinus surgery. 1st edition. Philadelphia: B.C. Decker, 1991.
79. Jung TTK, Juhn SK, Hwang D, Stewart R. Prostaglandins, leukotrienes, and other arachidonic acid metabolites in nasal polyps and nasal mucosa. Laryngoscope 1987;97: 184-9.
80. Lee TH. Mechanisms of aspirin sensitivity. Am Rev Respir Dis 1992;145(2)(Suppl.):S34-6.
81. Small P, Black M, Frenkiel S. Effects of treatment with beclomethasone dipropionate in subpopulations of perennial rhinitis patients. J Allergy Clin Immunol 1982;70:178-82.
82. Drake-Lee AB. Medical treatment of nasal polyps. Rhinology 1994;32(1):1-4.
83. Kanai N, Denburg J, Jordana M, Dolovich J. Nasal polyp inflammation. Effect of topical nasal steroid. Am J Respir Crit Care Med 1994;150:1094-100.
84. Booth H, Richmond I, Ward C, Gardiner FV, Harkawat R, Walters EH. Effect of high dose inhaled fluticasone propionate on airway inflammation in asthma. Am J Respir Clin Care Med 1995;152(1):45-52.
85. Sur S, Crotty TB, Kephart GM et al. Sudden onset fatal asthma: a distinct entity with few eosinophils and relatively more neutrophils in the airway submucosa? Am Rev Respir Dis 1993;148:7713-9.
86. Barnes PJ. Cholinergic control of airway smooth muscle. Am Rev Respir Dis 1987;136(4):S42-5.
87. Zaagsma J, van Amsterdam RGM, Brouwer F et al. Adrenergic control of airway function. Am Rev Respir Dis 1987;136(4):S45-50.
88. Barnes PJ. Neuropeptides in human airways: function and clinical importance. Am J Respir Dis 1987;136(6):77-83.
89. Laitinen LA, Laitinen A. Innervation of airway smooth muscle. Am J Respir Dis 1987;136(4):S38-42.
90. Palmer JBA, Barnes PJ. Neuropeptides and airway smooth muscle. Am J Respir Dis 1987;136(4):S50-S4.
91. McDonald DM. Neurogenic inflammation in the respiratory tract. Am Rev Respir Dis 1987;136(6):S65-72.
92. Payan DG, Goetzl EJ. Substance P receptor dependent responses of leukocytes in pulmonary inflammation. Am J Respir Dis 1987;136(6):S39-43.
93. Borum P, Mygind N, Schultz Larsen F. Intranasal ipratropium: a new treatment for perennial rhinitis. Clin Otolaryngol 1979;4:407-11.
94. O'Flynn P, Cumberworth V, Milford C, Mackay I. Trans-nasal electrocoagulation of the vidian nerve. Rhinology 1993;31(2):73-5.
95. Togias AG. Non-allergic rhinitis. In: Mygind N, Naclerio R, editors. Allergie and non-allergic rhinitis. Copenhagen: Munksgaard, 1993:159-66.
96. Mygind N, Weeke B. Allergie and non-allergic rhinitis. In: Middleton E, Reed CE, Ellis EE editors. Allergy principles and practice. St. Louis: CV Mosby Co, 1983;1101-17.
97. Blom HM, van Rijswijk JB, Garrelds IM, Mulder PGH, Gerth van Wijk R. The effect of capsaicin on nasal complaints and inflammatory mediators in the nasal mucosa of patients with VMR. A placebo-controlled study [Abstract]. Second symposium on experimental rhinology and immunology of the nose, 1996:39.
98. Stjärne P, Lundblad L, Lundberg JM, Angaard A. Capsaicin and nicotine-sensitive afferent neurones and basal secretion in healthy human volunteers and in patients with vasomotor rhinitis. Br J Pharmacol 1989;96:693-701.
99. Lacroix JS, Buvelot JM, Polla BS, Lundberg JM. Improvement of symptoms of non-allergic chronic rhinitis by local treatment with capsaicin. Clin Exp Allergy 1991;21: 595-600.
100. Stjärne P, Lundblad L, Angaard A. Local capsaicin treatment of the nasal mucosa reduces symptoms in patients with non-allergic nasal hyperreactivity. Am J Rhinol 1991; 5:145-51.
101. Holzer P. Capsaicin: cellular targets, mechanisms of action, and selectivity for thin sensory neurons. Pharmacol Rev 1991;43:143-201.
102. Karlsson J-A. A role for capsaicin sensitive, tachykinin containing nerves in chronic coughing and sneezing but not in asthma: a hypothesis. Thorax 1993;48:396-400.
103. Hathaway TJ, Higenbottam TW, Morrison JF, Clelland CA, Wallwork J. Effects of inhaled capsaicin in heart-lung transplant patients and asthmatic subjects. Am Rev Respir Dis 1993;148(5):1233-7.
104. Woodhead CJ. Neuropeptides in nasal mucosa. Clin Otolaryngol 1994;19(4):277-86.
105. Mullarkey MF, Hill JS, Webb DR. Allergic and nonallergic rhinitis: their characterization with attention to the meaning of nasal eosinophilia. J Allergy Clin Immunol 1980; 65(2):122-6.
106. Deal EC, McFadden ER, Ingram RH, Breslin FJ, Jaeger J. Airway responsiveness to cold air and hyperpnea in normal subjects and in those with hay fever and asthma. Am Rev Respir Dis 1980;121:621-8.
107. Rucci L, Masini E, Arbi-Riccardi R, Gianella E, Fioretti C, Mannaioni PF. Vidian nerve resection, histamine turnover and mucosal mast cell function in patients with chronic hypertrophic non-allergic rhinitis. Agents Actions 1989;28: 224-30.
108. Pipkorn U, Karlsson G, Enerback L. Phenotypic expression of proteoglycan in mast cells of the human nasal mucosa. Histochem J 1988;20;519-25.
109. Larocca LM, Maggiano N, Capelli A et al. Immunopath-ology of nasal polyps: an immunohistochemical approach. Ann Allergy 1989;63:508-12.
110. Mygind N. Nasal polyposis. J Allergy Clin Immunol 1990; 86(6):827-9.
111. Ruhno J, Howie K, Anderson M et al. The increased number of epithelial mast cells in nasal polyps and adjacent turbinates is not allergy-dependent. Allergy 1990; 45(5):370-4.
112. Probst L, Stoney P, Jeney E, Hawke M. Nasal polyps, bronchial asthma, and aspirin sensitivity. J Otolaryngol 1992;21(1):60-5.
113. Drake-Lee AB. Nasal polyps. In: Mygind N, Naclerio RM, editors. Allergic and non-allergic rhinitis. Clinical aspects. 1st edition. Copenhagen: Munksgaard, 1993:167-73.
114. Drake-Lee A, Jines V, Lewin I, Nayyar S, Wells A, Stanworth D. Levels of substance P and IgE decapeptide in nasal polyp fluid and matching sera: a preliminary study. J Laryngol Otol 1996;110:225-7.
115. Raphael GD, Meredith SD, Baraniuk JN, Kaliner MA. Nasal reflexes. In: Settipane GA, editor. Rhinitis. Providence, RI: OceanSide Publications, Inc., 1991:135-48.
116. Yan K, Salome C. The response of the airway to nasal stimulation in asthmatics with rhinitis. Eur J Respir Dis 1983;64(Suppl. 128):105-8.
117. Proctor DF. The upper airways. I. Nasal physiology and defense of the lungs. Am Rev Respir Dis 1977;115:97.
118. Aubier M, Levy J, Clerici C, Neukirch F, Herman D. Different effects of nasal and bronchial glucocorticoster-oid administration on bronchial hyperresponsiveness in patients with allergic rhinitis. Am Rev Respir Dis 1992; 146:122-6.
119. Naclerio RM, Mygind N. Intranasal steroids. In: Mygind N, Naclerio RM, editors. Allergic and non-allergic rhinitis. Copenhagen: Munksgaard, 1993:114-22.
120. Watson WTA, Becker AB, Simons FER. Treatment of allergic rhinitis with intranasal corticosteroids in patients with mild asthma: effect on lower airway responsiveness. J Allergy Clin Immunol 1993;91(1):97-101.
121. Wigand ME. Endoscopic surgery of the paranasal sinuses and anterior skull base. 1st edition. Stuttgart: Georg Thieme Verlag, 1990.
122. Friedman WH, Katsantonis GP. Intranasal and transantral ethmoidectomy: a 20-year experience. Laryngoscope 1990;100:343-8.
123. Jankowski R, Moneret-Vautrin DA, Goetz R, Wayoff M. Incidence of medico-surgical treatment for nasal polyps on the development of associated asthma. Rhinology 1992;30:249-58.
124. Settipane GA. Nasal polyps. In: Settipane GA, editor. Rhinitis. 2nd edition. Providence, RI: OceanSide Publications, Inc., 1991:173-83.